Olivier Litzka

Dr. Olivier Litzka has been a partner at Andera Partners, formerly Edmond de Rothschild Investment Partners (EdRIP), since 2006. He has over 15 years’ experience in private equity investments focused on life sciences. Dr. Litzka currently serves on our Board of Directors and is a member of our Compensation Committee.

Dr. Litzka is currently a board member at Allecra Therapeutics GmbH, Autonomic Technologies, Inc., NOXXON Pharma AG, and Supersonic Imagine; and was previously a board member at Arvelle Therapeutics, Sapiens Steering Brain Stimulation GmbH, Probiodrug AG, Small Bone Innovations, Inc., and Novexel SA up until their respective acquisition/IPO.

Prior to Andera Partners, Dr. Litzka was a partner at 3i Group PLC where, over his six-year term, he served on the boards of several portfolio companies and made a range of international investments. He started his career as a management consultant with Mercer Management Consulting GmbH.

Dr. Litzka holds a Ph.D. in Molecular Microbiology from the Institut für Mikrobiologie at the University of Munich and completed his scientific research in Munich and Oxford.